Atrac-Tain er udviklet og testet på diabetiske fødder.

AnvendelseI starten masseres et tyndt lag creme ind i huden 2-3 gange dagligt. Fortsæt derefter behandlingen 1 gang dagligt, så huden holdes elastisk og stærk. Bør ikke påføres mellem tæerne. Cremen er let at anvende og efterlader ikke huden fedtet.

∙ Fugter og blødgør tør og revnet hud

∙ Effektiv i forebyggelse af tør hud

og fissurer

∙ Indeholder 10% carbamid og

4% laktat med keratolystik effekt

Atrac-Tain®

Moisturising cream for diabetic feet

· Exfoliates and softens severely dry,

cracked, calloused skin

· Effective help for the prevention of diabetic

foot ulcers

· Contains 10% Urea and 4% Lactic Acid

(AHA) for keratolytic effect

Atrac-Tain® is developed for and reviewed on diabetic feet

USAGEIn the beginning of the treatment, a thin layer of cream is massaged into the skin 2-3 times daily. When the skin is healed, a treatment once daily secures that the skin is kept elastic and strong. Should not be used between the toes.The cream is easy to use and leaves the skin non-greasy.

Atrac-Tain®

Blødgørende creme til hård hud på fødder, hænder og albuer

F

FF

CPWSC_Atrac-Tain_Fachtsheet_A4_DK.indd 1 03/03/16 15.09

Tør hud - et alvorligt problemNæsten alle mennesker med diabetes (både type 1 og 2) oplever hudproblemer. Det mest almindelige problem er tør hud (xerosis).

Nedsat blodgennemstrømning i de små kar i fødderne medfører hudatrofi, hårtab, kolde tæer, dårlige negle og tør hud i forskellige grader. Autonom neuropati, som er en hyppig senkomplikation til diabetes, giver forstyrrelser i svedproduktionen, perifer erythem, ødem og atrofi og endda forværring af den tørre hud. Ubehandlet tør hud kan udvikle sig til fissurer med risiko for sårdannelse.1

Hvis foden så også bliver udsat for et øget tryk og friktion, så øges risikoen for sårdannelse yderligere.

Forebyggelse af diabetiske fodsårForebyggelse af sår er vigtig, fordi sår medfører store gener for patienten, og samtidig kan forværres med risiko for amputation.

Sårdannelse kan opstå, når der opbygges hård hud og fissurer. Begge dele kan forebygges ved at bruge en blødgørende creme regelmæssigt til diabetiske fødder.Atrac-Tain er derfor vigtig i plejen af fødderne, da den holder huden intakt og samtidig forebygger fissurer og sår.

Udviklet og testet på diabetiske fødderAtrac-Tain er udviklet til diabetikere og er effektiv i forebyggelse og behandling af xerosis på fødderne.1

Billederne her viser før og efter behandling med Atrac-Tain.

Fugter og blødgør hudenAtrac-Tain indeholder 10% carbamid og 4% laktat. Begge dele er naturligt forekommende fugtbevarende stoffer i huden.2-4 Carbamid virker som fugtgiver, der trænger igennem det ydre lag af stratum corneum, hvor det binder fugt. Laktat stimulerer afskalningen af epidermis. Hudens celler stimuleres til ny vækst, som giver huden et nyt blødt udseende. Laktat øger ligesom carbamid vandindholdet i stratum corneum.

De to fugtgivere genskaber hudens fugtighed og elasticitet indefra uden at lukke porerne.

Atrac-Tain indeholder ikke konserveringsmidler eller parfume.

IndholdsstofferVand, carbarmid, isopropyl palmitat, ethylhexyl pamitat, glyceryl stearat, laktat, stearyl alkohol, sorbitol, ammonium laktat, steraric acid, cetearet-25, cetearet-t.

Atrac-Tain® er effektiv til forebyggelse af diabetiske fodsår

1. Dr. Pham, Dr. Veves, Deaconess Joslin Foot Center, Beth Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, L. Exelbert, RN, MS, ACCE, A. Segal- Ovens RN, BSN, MSPH, CDE, The Diabetes Care Center at Baptist Hospital of Miami, Florida, USA: A Controlled Double-blind Multicenter Study of a Moisturizer Containing 4% Lactic Acid and 10% Urea (versus the vehicle for xerosis of the feet in patients with diabetes). 2. Serup, Jørgen, MD. Ph.D., A Double-blind Comparison of Two Creams Containing Urea as the Active Ingredient. Published in ActaDerm Venereol, Suppl. 177, 34-38, 1992. 3. Van Scott, Eugene, J. MD. Et Yu, Ruey J., Ph.D., OMD, Actions of Alpha Hydroxy Acids on Skin Compartments. Published in The Journal of Geriatric Dermatology, Vol. 3, April 1995. 4. Leyden, James J., MD., Lavker, Robert M., Ph.D., Grove, Gary Ph.D. et Kaidbey, Kays MD, Alpha Hydroxy Acids are More than Moisturizers. Published in The Journal of Geriatric Dermatology, Vol. 3, April 1995.

Atrac-Tain Varenummer Størrelse Antal i æske

4738 75 ml 12

Item code Size Units per box

4738 75 ml 12

Coloplast A/S

Holtedam 1

3050 Humlebæk

Denmark

www.coloplast.com

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people

who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care,

urology and continence care and wound and skin care. We operate globally and employ more than 7,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © [2010-05]

All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

Dry skin – a severe problem

Almost everyone with Diabetes Mellitus (both type 1 and

type 2) suffers from some kind of skin problem. The most

common problem is xerosis, also known as dry skin.

Impaired blood fl ow in the small vessels causes skin atro-

phy, hair loss, coldness of toes, nail dystrophies and dry

skin of all degrees. Autonomic neuropathy, which is a fre-

quent late complication to diabetes, may cause distur-

bances in sweat production, peripheral erythema, edema,

atrophy and even aggravation to the dry skin. Untreated

dry skin can develop fi ssures with a risk of ulceration.

Additionally, when the foot is exposed to increased pres-

sure and friction, the risk of developing a foot ulcer in-

creases.

Prevention of diabetic ulceration

Prevention of ulcers is important, as they not only cause

signifi cant discomfort and inconvenience for the patient,

but most importantly, can lead to amputation.

Ulceration occurs when callosity and fi ssures are in-

creased. This situation can be prevented by using a

moisturising cream formulated for the needs of the dia-

betic foot on a regular basis. Atrac-Tain is therefore an

important supplement for foot care because it helps the

skin to remain intact and at the same time prevents fi s-

sures and skin trauma.

Developed and reviewed on diabetic feet

Atrac-Tain was developed for diabetic patients and has

been proven to be effective in the prevention and treat-

ment of diabetic foot complications. This is how the

cream was proven safe and effective in use1.

Studies have proven the effectiveness of Atrac-Tain2.

The following before and after pictures are from a clinical

study of treatment with Atrac-Tain.

Nourishes and moisturises the skin

Atrac-Tain contains 10% Urea and 4% Lactic Acid (Alpha

Hydroxy Acid, AHA). Both of these are native moisturis-

ers in the skin3-5. Urea is a moisturiser penetrating the

external layers of stratum corneum, where it binds liquid.

Lactid Acid stimulates the exfoliation of the epidermis.

The exfoliation causes the skin to generate regrowth, giv-

ing the skin a smooth new look. Urea as well as Lactid

Acid increases the content of liquid in stratum corneum.

Together the two moisturisers restore the humidity and

the elasticity of the skin from inside without closing the

pores.

Atrac-Tain contains no preservatives, dye or perfume,

minimising the risk of allergic reactions on sensitive dia-

betic skin.

How to use

In the beginning of the treatment, a thin layer of cream is

massaged into the skin 2-3 times daily. When the skin is

healed, a treatment once daily secures that the skin is

kept elastic and strong. Should not be used between

the toes.

The cream is easy to use and leaves the skin non-greasy.

Composition

Aqua, Urea (Carbamid), Isopropyl Palmitate, Octyl

Palmitate, Glyceryl Stearate, Lactic Acid, Stearyl Alco-

hol, Sorbitol, Ammonium Lactate, Steraric Acid, Cete-

areth-25, and Ceteareth-6.

Atrac-Tain

References:

1. Dr. Pham, Dr. Veves, Deaconess Joslin Foot Center, Beth Deaconess Medical Center and

Harvard Medical School, Boston, Massachusetts, L. Exelbert, RN, MS, ACCE, A. Segal-

Ovens RN, BSN, MSPH, CDE, The Diabetes Care Center at Baptist Hospital of Miami,

Florida, USA: A Controlled Double-blind Multicenter Study of a Moisturizer Containing 4%

Lactic Acid and 10% Urea (versus the vehicle for xerosis of the feet in patients with diabetes).

2. Huckestein, Lynda, RN, BSN, CWOCN Certifi ed Wound, Ostomy, Continence Nurse,

UPMC, St. Margaret Hospital. Treatment of Xerosis in Two Patients with Peripheral Vascular

Disease. Presented at the: Clinical Symposium on Advances in Skin and Wound Care, Las

Vegas, NV, Oct. 23 - 26th, 2005.

3. Serup, Jørgen, MD. Ph.D., A Double-blind Comparison of Two Creams Containing Urea as

the Active Ingredient. Published in ActaDerm Venereol, Suppl. 177, 34-38, 1992

4. Van Scott, Eugene, J. MD. Et Yu, Ruey J., Ph.D., OMD, Actions of Alpha Hydroxy Acids on

Skin Compartments. Published in The Journal of Geriatric Dermatology, Vol. 3, April 1995.

5. Leyden, James J., MD., Lavker, Robert M., Ph.D., Grove, Gary Ph.D. et Kaidbey, Kays

MD, Alpha Hydroxy Acids are More than Moisturizers. Published in The Journal of Geriatric

Dermatology, Vol. 3, April 1995

Atrac-Tain®

Moisturising cream for diabetic feet

Before treatment:

A 65-year-old man with

very dry skin and fi ssures.

After treatment:

4 weeks after treatment

with Atrac-Tain, the skin is

now soft and intact.

Før:En 65-årig mand med meget tør hud og fissurer på hælen.

Efter:4 ugers behandling med Atrac-Tain. Huden er nu blød og intakt.

Coloplast Danmark A/S, Holtedam 1, 3050 Humlebæk, Denmark

www.coloplast.dk Coloplast logo er et registreret varemærke ejet af Coloplast A/S. © 2016-03. Alle rettigheder forbeholdes Coloplast A/S. WC0030

CPWSC_Atrac-Tain_Fachtsheet_A4_DK.indd 2 03/03/16 15.09